EUVIMEDEUVIMED entdecken
Open Access

Feasibility and Outcomes of Mitral Transcatheter Edge‐To‐Edge Repair in Patients With Variable Degrees of Mitral Annular Calcification

Taha Hatab iD, Rody G Bou Chaaya, Syed Zaid iD, Priscilla Wessly, Priyanka Satish iD, Victoria Villanueva, Nadeen Faza, Stephen H Little iD, Marvin D Atkins iD, Michael J Reardon iD, Neal S Kleiman iD, William A Zoghbi iD und 1 weitere

Journal of the American Heart Association · 03.10.2023 · 12 (19)

DOI: 10.1161/jaha.123.031118 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 03.10.2023. Verfasst von Taha Hatab und 12 weiteren Autor:innen. Beteiligte Einrichtung: Houston Methodist DeBakey Heart and Vascular Center Houston TX. Hauptthemen laut MEDLINE: Mitral Valve Insufficiency, Heart Valve Prosthesis Implantation, Heart Valve Diseases, Calcinosis. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The clinical significance of mitral annular calcification (MAC) in patients undergoing mitral transcatheter edge‐to‐edge repair is not well understood. There is limited evidence regarding the feasibility, durability of repair, and the prognostic value of MAC in this population. We sought to examine the prognostic value of MAC, its severity, and its impact on procedural success and durability of mitral transcatheter edge‐to‐edge repair. Methods and Results We reviewed the records of 280 patients with moderate–severe or severe mitral regurgitation who underwent mitral transcatheter edge‐to‐edge repair with MitraClip from March 2014 to March 2022. The primary end point was cumulative survival at 1 year. Independent factors associated with the primary end point were identified using multivariable Cox regression. Among 280 patients included in the final analysis, 249 had none/mild MAC, and 31 had moderate/severe MAC. Median follow‐up was 23.1 months (interquartile range: 11.1–40.4). Procedural success was comparable in the MAC and non‐MAC groups (92.6% versus 91.4%, P =0.79) with similar rates of residual mitral regurgitation ≤2 at 1 year (86.7% versus 93.2%, P =0.55). Moderate/severe MAC was associated with less improvement in New York Heart Association III/IV at 30 days when compared with none/mild MAC (45.8% versus 14.3%, P =0.001). The moderate/severe MAC group had lower cumulative 1‐year survival (56.8% versus 80.0%, hazard ratio [HR], 1.98 [95% CI, 1.27–3.10], P =0.002). Moderate/severe MAC and Society of Thoracic Surgeons predicted risk of mortality for mitral valve repair were independently associated with the primary end point (HR, 2.20 [1.10–4.41], P =0.02; and HR, 1.014 [1.006–1.078], P =0.02, respectively).

Conclusions

Mitral TEER is a safe and feasible intervention in selected patients with significant MAC and associated with similar mitral regurgitation reduction at 1 year compared with patients with none/mild MAC. Patients with moderate/severe MAC had a high 1‐year mortality and less improvement in their symptoms after TEER.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mitral Valve InsufficiencyHeart Valve Prosthesis ImplantationHeart Valve DiseasesCalcinosisHumansMitral ValveFeasibility StudiesTreatment OutcomeCardiac Catheterization

Stichwörter der Autor:innen

TEERmitral annular calcificationmitral regurgitation

Autor:innen und Institutionen

  • Houston Methodist DeBakey Heart and Vascular Center Houston TX.
  • Department of Cardiovascular Surgery Houston Methodist Hospital Houston TX.

ORCID-Profile: Taha Hatab, Syed Zaid, Priyanka Satish, Stephen H Little, Marvin D Atkins, Michael J Reardon, Neal S Kleiman, William A Zoghbi, Sachin S Goel

Zitieren

APA

Hatab, T., Bou Chaaya, R. G., Zaid, S., Wessly, P., Satish, P., Villanueva, V., Faza, N., Little, S. H., Atkins, M. D., Reardon, M. J., Kleiman, N. S., Zoghbi, W. A., & Goel, S. S. (2023). Feasibility and Outcomes of Mitral Transcatheter Edge‐To‐Edge Repair in Patients With Variable Degrees of Mitral Annular Calcification. Journal of the American Heart Association, 12(19). https://doi.org/10.1161/jaha.123.031118

Vancouver

Hatab T, Bou Chaaya RG, Zaid S, Wessly P, Satish P, Villanueva V, et al. Feasibility and Outcomes of Mitral Transcatheter Edge‐To‐Edge Repair in Patients With Variable Degrees of Mitral Annular Calcification. Journal of the American Heart Association. 2023;12(19). doi:10.1161/jaha.123.031118

BibTeX
@article{Hatab2023,
  author = {Hatab, Taha and Bou Chaaya, Rody G and Zaid, Syed and Wessly, Priscilla and Satish, Priyanka and Villanueva, Victoria and Faza, Nadeen and Little, Stephen H and Atkins, Marvin D and Reardon, Michael J and Kleiman, Neal S and Zoghbi, William A and Goel, Sachin S},
  title = {Feasibility and Outcomes of Mitral Transcatheter Edge‐To‐Edge Repair in Patients With Variable Degrees of Mitral Annular Calcification},
  journal = {Journal of the American Heart Association},
  year = {2023},
  volume = {12},
  number = {19},
  doi = {10.1161/jaha.123.031118}
}
Kostenlos starten →